SCHEMBL4560549

SCHEMBL4560549

O=C1CNC2(CCC(S(=O)(=O)c3ccc(-c4ccc5occc5c4)cc3F)CC2)CC1C1CC1

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CA12 O43570 6/20 0.36
CA2 P00918 7/20 0.33
FASN P49327 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4562348 0.81 KDM4E (0.31) FASN
SCHEMBL4564691 0.80 FASN (0.36) FASN
SCHEMBL4565721 0.78 ALOX5AP (0.32)
SCHEMBL4565459 0.78 ALOX5AP (0.35) FASN
SCHEMBL4565373 0.72
SCHEMBL4564697 0.70 CHRNA7 (0.33) FASN
SCHEMBL4565380 0.68 ALOX5AP (0.36)
SCHEMBL4565553 0.67 FGFR1 (0.37)
SCHEMBL4569982 0.67 PTPN1 (0.39) FASN
SCHEMBL4565577 0.65 SGK1 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2637660-A1 FATTY ACID SYNTHASE INHIBITORS Glaxosmithkline Intellectual Property (No. 2) Limited (GB) 2013-09-18 EP disclosed
WO-2012064642-A1 FATTY ACID SYNTHASE INHIBITORS GLAXOSMITHKLINE LLC (US) 2012-05-18 WO disclosed